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Since Andreas Gruentzig1 first introduced percutaneous 
transluminal coronary angioplasty (PTCA) in 1977, the ability to 
revascularize occluded coronary vessels with a catheter has 
enjoyed an explosive and unimaginable growth. As the equipment 
and operator experience improved, the possibilities appeared 
boundless. However, balloon angioplasty is hampered by a signifi-
cant restenosis rate in the dilated vessel (approximately 30% ), 
which is higher in selected locations (up to 60% in the proximal left 
anterior descending artery), even in the best of hands. This 
fundamental/imitation may in part be due to the actual nature of 
the technique itself-stretching the vessel and fissuring the plaque 
causing remodeling without removal. The uneven, exposed vessel 
suiface post-plaque rupture may contribute to activation of the 
hemostatic system, with acute thrombosis and release of various 
platelet and endothelial-derived growth factors, leading to long-
term tissue proliferation and restenosis. Atherectomy, the me-
chanical removal of plaque from the vessel wall, appears to be an 
answer. This process actually de bulks the culprit tissue and leaves 
behind a smoother, presumably less thrombogenic suiface. We 
wish to report our first experience with a specific form of this 
technique in 4 consecutive patients, with a brief discussion of its 
promises and limitations. 
Technique 
Atherectomy currently can be performed percutaneously by a 
catheter. There are 3 major techniques: Directional, rotational and 
ex tractional. Only the directional form is approved by the FDA for 
coronary circulation and was the technique used in all our patients. 
Directional atherectomy was developed by John B. Simpson 
MD at Sequoia Hospital in Redwood City, California in 1985, first 
for the peripheral vessels of the human body. Coronary work 
started in 19862• The directional coronary atherectomy (DCA) 
catheter basically consists of a cup-shaped cutter housed in a rigid 
cylindrical metallic case at the catheter tip. This case has a 
longitudinal window along one side and an inflatable long balloon 
on the opposite side. There is a flexible nose cone which serves to 
hold back the cut tissue and also minimizes tissue trauma as the 
catheter is advanced inside the vessel. The entire catheter is guided 
by a steerable 0.014 inch guide-wire which is threaded coaxially 
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through the entire catheter (including the cutter). The cutter is 
connected by a hollow cable to a hand-held, battery-driven motor 
unit that spins the cutter at 2,000 rpm. The cutter can be manually 
advanced or retrieved by a proximal lever. 
During the procedure, the catheter is delivered to the culprit 
vessel in a 10 or 11 French guiding catheter, introduced percutane-
ously through the femoral artery. T:1e technique is similar to 
PTCA. The lesion is traversed with the guide-wire, over which the 
catheter is advanced. The opening in the distal casing is then 
oriented across the lesion. The balloon is inflated by a manually 
controlled device with pressures ofl 0 to 40 psi, to push the window 
against the atheromatous plaque. The cutter is withdrawn, the drive 
unit is turned on, and the spinning cutter is slowly advanced across 
the window, shearing off the tissue in the process (Figure 1). The 
balloon is deflated and the catheter is torqued manually 45° to 90° 
to orient the window to a different part of the plaque. The process 
is then repeated. The cuts are generally made circumferentially 
(360°) or directionally if the plaque is eccentric, with progressively 
increasing balloon inflation pressures, to allow for deeper cuts. A 
larger device can be used if the end result is less than satisfactory 
(the AtheroCath is available in 3 sizes: SF, 6F and 7F). 
Simpson had previously recommended leaving a residual 
lesion of no more than 30%. The current practice is to make the 
vessel as normal appearing as possible as there is increasing 
evidence to suggest that a more complete atherectomy reduces 
restenosis3• 
The patients are all premedicated with aspirin and fully 
anticoagulated with intravenous heparin at the time of the proce-
dure, maintaining an activated clotting time of >350 sec. Post-
procedure, because of the size of the arterial sheath, close attention 
must be paid to the circulatory status of the distal extremity. It is 
common practice to remove the sheath on the same day. 
The concept is highly attractive, ie the mechanical removal of 
the offending plaque. In reality, much of the angiographic im-
provement following DCA is due to the Dotter effect, much akin 
to the mechanism of PTCA action-a physical dilatation of the 
lumen with the catheter and the inflated balloon4• Therefore, it 
behooves the operator to avoid using excessively high inflation 
pressures, such that there is more cutting and less dottering. It is 
estimated that actual tissue removal contributes to about 25% of the 
angiographic luminal improvement5• 
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CORONARY ATHERECTOMY (continued from page 325) 
Case reports 
Case No. 1 is a 70-year-old housewife with hypertension, 
hypercholesterolemia, type II diabetes mellitus and idiopathic 
hypertrophic subaortic stenosis (IHSS). She had exertional angina 
and was found to have serial (75%, 90%) proximal left anterior 
descending (LAD) and 80% proximal ramus intermedius lesions, 
with vigorous left ventricular (LV) systolic function and ejection 
fraction (EF) over 7 5%. She had undergone successful PTCA of the 
above lesions. Three months later, she had recurrent angina and 
was found to have restenosis of a proximal LAD lesion to 90%. 
She underwent DCA of her obstruction with a 6 French DVI 
(Devices for Vascular Intervention, Inc., Redwood City, California) 
Simpson AtheroCath at our facility. The maximum pressure was 25 psi 
and a total number of9 cuts were made circurnferentially, reducing the 
lesion initially to 0%, with six pieces of tissue removed. About half an 
hour later, the patient developed abrupt hypotension (50 to 60 mmHg 
Figure 1. Mechanism of directional coronary atherectomy (DCA). 
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Coronary artery with an eccentric stenosis. A 0.014-inch 
guide wire has just been threaded across the lesion . 
B 
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Over the guide-wire, the DVI Simpson AtheroCath is ad-
vanced across the obstruction with the window facing the bulk 
of the eccentric lesion. Note that the wire is coaxial ; it runs 
through the center of the catheter including the cutter (shaded 
black). The cup-shaped cutter is pulled back proximally 
before the cut. 
The balloon is inflated to 15 psi pushing the window firmly into 
the plaque. 
The drive unit is turned on, spinning the cutter at 2,000 rpm. 
The cutter then is gently and slowly advanced across the 
window, shaving off the plaque in the process. The 
atherectomized tissue is pushed distally into the soft nose 
cone, which serves as a reservoir. 
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After the cut(s) , the catheter and guide-wire are withdrawn. 
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systolic) without chest discomfort or electrocardiographic ST-T wave 
changes. She also had recurrent ventricular tachycardia-fibrillation, 
requiring direct-current cardioversion. 
An intra-aortic balloon counterpulsation (IABP) catheter was 
inserted and I: I counterpulsation was begun. Angiography re-
vealed complete occlusion of the LAD beyond the site of 
atherectomy. The vessel was dilated with a 2.5 mm coronary 
perfusion catheter. Even though patency was achieved within 15 
minutes from the onset of hypotension, the patient remained in 
shock. She was intubated and ventilated artificially. There was a 
large output of pinkish fluid from the endotracheal tube, consistent 
with pulmonary edema. Systolic pressure was only 30mmHg 
despite maximal pressor and mechanical support. 
Figure 2A. Case No. 2. Ninety percent proximal 
left anterior descending (LAD) stenosis. 
Figure 28. Seven F AtheroCath across obstruction. 
The spinning cutter is one-third the way across the 
cutting window. 
Figure 2C. Same lesion post DCA with residual 
stenosis of 1 0%. 
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The right femoral artery and vein were cannulated and extra-
corporeal cardiopulmonary bypass with the CPS system was 
begun. She was moribund when she was brought to the operating 
room. She received saphenous venous grafting of her LAD and 
right coronary artery (which had a 50% proximal lesion). The 
culprit vessel was inspected: there was good antegrade flow 
without thrombus or perforation. 
Somewhat surprisingly, she was easily weaned from cardio-
pulmonary bypass with the frrst attempt in the operating room. IABP 
and pressor support were discontinued by the fourth postoperative day. 
The maximum creatine kinase (CK) was 4,829 units/L (8.0% MB). 
She expired 8 months post-procedure from respiratory failure 
and urinary sepsis. 
Case No.2 is a 61-year-old retired man with a 45 pack-year 
smoking history and hypercholesterolemia. He had exertional 
chest pressure; the treadmill stress test was positive. Catheterization 
revealed a 90% proximal LAD lesion, 90% proximal circumflex 
marginal lesion and distal right coronary artery disease. EF was 
normal at 60%. He had successful PTCA of the LAD and marginal 
lesions (to 30% and 10% respectively). 
Chest pain recurred with restenosis of the LAD lesion to 90% (Figure 2A). Successful DCA was performed, using fust a 6F DVI 
Simpson AtheroCath with a series of 16 circumferential cuts (maximum pressure 35 psi). This was followed by a 7F AtheroCath 
with 4 cuts (maximum pressure of 20 psi)(Figure 2B). The lesion 
was reduced to 10% (Figure 2C). Moderate amounts of tissue were 
removed (Figure 3). CK was normal post procedure. The patient is 
well after 1 year of follow-up. 
Case No.3 is a 49-year-old man with hypertension and former 
smoking history. In 1979, because of angina, he had a cardiac 
catheterization done which revealed LAD disease. In 1989, he had 
1-vessel saphenous vein grafting of the LAD done elsewhere. In 
early 1991, he nearly drowned while bodysurfing. After struggling 
back to shore, he developed severe, relentless chest pain. He was 
admitted to our facility with a non-Q wave myocardial infarction. 
CK was 794 units/L (11.3% MB). 
A thallium treadmill test was positive for an anterolateral 
ischemic defect. Catheterization revealed an 80% mid-lesion in the 
LAD venous graft, with total occlusion of the LAD proximally 
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Figure 3. Atheromatous tissue removed from the proximal LAD 
in patient Case No. 2. 
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(Figure 4A). There was moderate anterior hypokinesis, with EF of 
60%. He underwent successful DCA of the graft lesion, with a 7F 
AtheroCath, employing 16 circumferential cuts (maximum pres-
sure 35 psi) (Figure 4B). The lesion was reduced to I 0% (Figure 
4C). CK was normal post-procedure. The patient remains pain-free 
on 10-month follow-up. 
Case No.4 is a 68-year-old retired man with hypertension. He 
had onset of severe chest pain in late 1991, with acute anterior MI. 
Catheterization revealed a 90% proximal LAD lesion involving a 
diagonal branch which had a 90% ostial occlusion as well. Both 
occlusions were dilated to 20% by PTCA. With recurrent angina, 
(Continued on page 328),.. 
Figure 4A. Case No.3. Eighty percent mid-lesion in 
saphenous vein graft to LAD. 
Figure 48. Seven F AtheroCath across obstruction 
in graft, with cutter pulled back proximally. 
Figure 4C. Same lesion post DCA with residual 
stenosis of 1 0%. 
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he was found to have restenosis of his LAD lesion to 80% 
eccentrically and the diagonal obstruction to 90% (Figure SA). 
The LAD lesion responded to a successful DCA with a 6F 
AtheroCath ( 11 cuts with maximum pressure 20 psi). Moderate 
amounts of tissue were removed. The lesion was reduced to less 
than 20%. An attempt was made to make this perfect with a 7F 
AtheroCath, with 5 cuts at low pressure (I 0 psi). Unfortunately, this 
did not remove more tissue but left the vessel with a small nose 
cone-induced dissection distal to the site of atherectomy (Figure 
5B), which was stable and acceptable in appearance (by repeat 
catheterization next morning). The ostial diagonal obstruction had 
successful balloon dilation to 20%. 
CK was negative afterward. The patient is well after 8-month 
follow-up. 
Discussion 
Our results 
Our cases are fairly typical of the routine patients considered 
for DCA. Retrospectively, the choice of Case No. 1 is suboptimal 
because of underlying IHSS. We now believe that IHSS constitutes 
a major risk factor for catheter interventional techniques for the 
LAD, the rationale of which we have reported elsewhere
6
• In our 
case, the vessel underwent abrupt closure, probably from dissec-
tion and/or spasm. Even though patency was reestablished within 
15 minutes after acute occlusion, the marked stunning of the 
massively hypertrophied septum had led to shock, worsening 
ventricular compliance and outflow obstruction, further decrease 
in coronary perfusion and spiraling hemodynamic consequences. 
We could not employ nitrates or calcium entry blockers because the 
patient was profoundly hypotensive. Immediate establishment of 
extracorporeal bypass percutaneously allowed us to perfuse the 
brain and vital organs. The ensuing hypothermia and cardiac 
decompression during emergent bypass presumably helped reduce 
myocardial oxygen demand and relax the stiff septum leading to 
hemodynamic recovery. 
The other cases were relatively simple. The technique left a 
very satisfactory angiographic result (smooth lumen, little to no 
residual stenosis). 
The equipment is rather cumbersome. The guiding catheters 
from DV1 were difficult to maneuver, the lOF being superior to the 
llF. The AtheroCath device is a throwback to the early days of 
PTCA. The trackability is quite poor, and lesions beyond an acute 
bend are virtually inaccessible. We also are concerned about the 
ever-present risk of dissecting the vessel with the stiff distal casing, 
as seen in Case No. 4. For native coronary artery stenosis, it has 
been our practice to restrict the use of DCA to restenosis after 
previous PTCA or for very eccentric primary lesions. In bypass 
grafts, we consider it as a first line catheter interventional tech-
nique, in part because the graft size frequently exceeds that of the 
largest PTCA balloon. 
Primary success rate of DCA 
Since this is a rapidly growing field, much of the data is 
available only in abstract form, and the same groups of patients are 
reported in various permutations. 
The multicenter SHAVE (Steerable Housi ng for 
AtheroVascular Excision) study, with an experience of 480 pa-
tients, revealed that the technique resulted in a primary success rate 
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Figure SA. Case No. 4. 80% eccentric LAD lesion with 90% ostial 
diagonal stenosis. 
Figure 58. Residual LAD lesion of 20% post-DCA (note small intimal 
dissection) and residual diagonal stenosis of 20% post- PTCA. 
close to 90%.2 Noncalcified lesions were better than calcified. 
There was a trend favoring LAD (over circumflex) and proximal 
(over ostial) lesions. The study had a significant selection bias 
because patients with tortuous vessels, diffuse disease or moderate 
to dense calcification were excluded. Thus the results are not 
directly comparable to those undergoing PTCA (which in experi-
enced hands has a primary success rate of 96% to 97%, for all 
lesions). A steep learning curve was also noted in the SHAVE study. 
Subsequently, the Sequoia group (which contributed the larg-
est percentage of patients to the various multicenter studies) 
reported the results of its 848 procedures 7• Their success rate had 
increased over time (37% in 1987 and 90% in 1989 and 1990), 
attesting to the validity of the learning curve. Factors associated 
with a lower success rate were: Calcified, angled or de novo lesions 
and the use of too small a device. 
The American College of Cardiology/ American Heart Asso-
ciation Task Force Report on the Guidelines for PTCN, classified 
coronary lesions into types A, B and C (Table 1 ) with type A 
occlusions anticipating the highest yield and lowest risk. Ellis etal
9
, 
in their study of 400 stenoses, recognized that DCA, like PTCA, 
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conformed very closely to these criteria for success and complica-
tions. The success rates were: Type A 93%, type Bl88%, type B2 
75% (there were too few type C lesions for analysis). 
Acute complications 
Abrupt closure occurred in 4.2% of cases in the multicenter 
studyl0• This was higher in primary, eccentric, and right coronary 
artery lesions. Abrupt closure was inversely related to the number 
of specimens obtained (ie, the more removed the better) and tended 
to be lower with saphenous venous grafts (p= 0.08). Two-thirds of 
patients with abrupt closure suffered an MI. 
Coronary perforation occurred in 1.3% of cases, none of 
whom developed tamponade, though one-third of the patients 
needed emergent bypass surgery 11 • The presence of media and 
especially adventitia in the excised specimens was correlated 
strongly with this outcome. 
The in-hospital death rate reported by the Sequoia group was 
0.35%7. 
There is some concern about peripheral vascular complica-
tions because of the large size of the arterial sheaths and guiding 
catheters. Thus far, an increased incidence has not been reported in 
literature. 
Lesion morphology was found by Ellis et al9 to have a sig-
nificant influence on major ischemic complications (death, myo-
cardial infarction and emergency bypass surgery). The complica-
tion rates were: Type A 3%, type Bl6%, type B2 13%, type C too 
few to analyze. In addition, they discovered that stenosis with 
angulation, proximal tortuosity, decreased preatherectomy mini-
mum lumen dimension and calcification correlated independently 
with adverse outcome. Extrapolating these data, it may be fair to 
estimate a major complication rate of 4% to 5% in experienced 
hands, with a death rate of approximately 0.5%. 
Restenosis 
Restenosis is the achilles' heel of PTCA and, therefore, the 
yardstick by which all new catheter interventional techniques will 
be measured. At least several mechanisms are involved: The elastic 
recoil of the vessel wall, the activation of the hemostatic system and 
the stimulation of smooth muscle proliferation post-injury. 
Debulking the plaque with DCA may reduce elastic recoil; producing 
a smoother surface may cause less thrombogenesis and smoother flow 
and hopefully less activation of platelet-derived growth factors. 
The Sequoia group reported that restenosis (defined as >50% 
stenosis evaluated at 6 months) occurred in 36% of native coronar-
ies (31% in primary and 40% in restenosed lesions) and 62% in 
saphenous venous grafts.7 
At first glance, DCA does not appear to offer significant 
advantage over PTCA in terms of restenosis. To address the 
question, the majorrandomized CAVEAT (Coronary Angioplasty 
Versus Excisional Atherectomy Trial) has been started in August, 
1991, with the aim of recruiting 1,000 patients by July, 1992. The 
final report is expected by the end of 1992. This hopefully will 
provide the much needed answers. Interestingly, Simpson has 
noted anecdotally that in one of his patients with repeated 
atherectomies the successive specimens showed progressively 
decreased proliferative elements. If this observation can be ex-
tended to more patients, the solution to restenosis post DCA may 
well be: "Keep shaving until it stops coming back". 
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Table 1. ACC/AHA Task Force assigned characteristics 
of PTCA Type A, B, C lesions 8 , as applied to DCA, with 
success/risk rates per Ellis et al 9• 
A• B•• C••• 
discrete 1 0-20mm >20mm 
readily accessible moderate proximal excessive proximal 
tortuosity tortuosity 
nonangulated >450, <900 >900 
nontotal total ( <3months) total (>3months) 
no side branch protectable side unprotectable side 
branch branch 
no Ca++ moderate-heavy Ca+ 
no thrombus thrombus 
nonostial ostial 
concentric eccentric 
smooth contour irregular contour 
degenerated friable 
vein graft 
success 93% success 81 88% 
82 75% 
risk 3% risk 81 6% 
82 13% 
* a type A lesion has to fulfill all of the following criteria. 
** a type B lesion has any one of the following criteria. Type a· 
has one characteristic, type 82 has 2. 
*** a type C lesion has any one of the following criteria. 
--
Advantages over PTCA 
For highly eccentric and ulcerated lesions, DCA is unques-
tionably superior to balloon dilatation in achieving satisfactory 
angiographic results immediately, offering smoother lumen and 
less residual stenosis. For elastic lesions, typically in the proximal 
LAD, this technique also offers a clear edge. 
DCA also may be a good salvage tool for localized dissections 
after balloon angioplasty. These flow-occluding tissue flaps are 
generally very responsive to atherectomy. 
At the same time, directional atherectomy offers a unique 
opportunity to obtain viable tissue for the study of atherogenesis, 
and this is being actively pursued both at the microscopid2 and 
molecular13 levels, eg it has been found that smooth-muscle-cell 
migratory velocity is much higher and human non-muscle myosin 
heavy chain-B mRNA is present in greater abundance in restenotic 
than in primary plaque material. 
Atherectomy by other means 
Mechanical Rotational Atherectomy (MRA) or Percutaneous 
Transluminal Coronary Rotational Ablation (PTCRA) is done by 
the Rotablator (Heart Technology, Inc., Bellevue, Washington). 
This instrument consists of an olive-shaped brass burr coated with 
fine diamond chips and connected to a flexible drive shaft. The burr 
can rotate at rates of 140,000 to 190,000 rpm, driven by a com-
pressed air turbine. The lesion is first crossed by a special coaxial 
0.009-inch guide-wire. The rotating burr is then pushed across the 
lesion, pulverizing the plaque into microparticles of less than 5 
micron diameter, which embolize distally into the coronary micro-
(Continued on page 330) ~ 
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vasculature and are cleared by the reticuloendothelial system. 
Initial results were encouraging14 .15• The immediate success, com-
plication and restenosis rates are equivalent to PTCA. The device 
is promising for calcified lesions and diffuse disease as well as in 
tortuous vessels. However, at least a third of the MRA patients 
require adjunctive PTCA. Furthermore, about 13% of patients 
demonstrate significant CK rise C~200 UIL with MB ?:.7.5 ng/ml) 
up to 24 hours post procedure 16• 
The Transluminal Extraction Catheter (TEC) (Interventional 
Technologies, Inc., San Diego, California), is the least well-
known of the 3 atherectomy devices. It consists of a hollow torque 
tube with a distal cutting cone of2 stainless steel blades. The lesion 
is first crossed over by a special stiff O.QJ 4-inch guide-wire. The 
conical cutter is then rotated at 7 50 rpm by a battery -operated drive 
unit. Lactated Ringer's solution is continuously infused through 
the guiding catheter and the debris is suctioned through the hollow 
tube into a collecting vacuum bottle. The experience with this 
device is limited. So far, it does not appear to offer any significant 
advantage over PTCN7, except that it seems to work well in 
thrombus-containing lesions 18 (hence a potential role in acute MI), 
diffuse disease and ostial disease19• A fairly large volume of blood 
may be aspirated along with the debris. At least two-thirds of 
patients require adjunctive PTCA following this technique. By 
comparison, less than 15% of patients undergoing DCA require 
additional balloon dilatation. 
The 3 methods of doing atherectomies, at their current level 
of development, have not surpassed PTCA in terms of ease of use 
or general applicability and are likely to serve as supplemental 
techniques. Within that framework, the 3 actually complement 
each other. For example, for elastic lesions, DCA and TEC are 
quite suitable. For diffuse disease or for distal lesions in small 
vessels, MRA may be better. For lesions containing thrombus or 
for obstructed degenerative saphenous venous grafts with copi-
ous, cheesy atheromatous material, TEC has the advantage. For 
ulcerated lesions, localized dissections and flaps, DCA should be 
considered. Of the 3, MRA may be the most user-friendly. 
Beyond PTCA and atherectomies 
The field of catheter interventional techniques is rapidly 
advancing. Lasers are gaining a strong foothold. Excimer laser 
coronary angioplasty (ELCA) already has been approved by the 
FDA for use in diffuse coronary disease and will likely have a 
useful role in total occlusions and saphenous venous graft lesions, 
including those appearing degenerative 20• Other forms of laser 
energy sources and naked-beam/heated-balloon catheters are un-
der development. Various forms of intracoronary stents21 also are 
being studied for treatment of acute dissections/abrupt closure and 
for the long-term prevention of restenosis. 
Ultimately, the solution may be at the molecular level with 
development of antibodies or factors that will antagonize smooth 
muscle proliferation and atherogenesis22 and with the early iden-
tification of genomes that are atherosclerosis prone, so that rigid 
control of risk factors and other preventive measures can be 
instituted at a young age. 
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Conclusion 
We have presented our early experience in 4 patients who 
underwent directional coronary atherectomy. It is a helpful ad-
junctive technique to PTCA; however, there is a steep learning 
curve and careful patient selection is the key to success. The 
currently available equipment is quite cumbersome and needs 
refinement. We have confined its use to recurrent or eccentric 
native coronary lesions and to primary lesions in clean saphenous-
venous bypass grafts. Whether the procedure is more effective 
than PTCA in reducing restenosis may be answered by an ongoing 
controlled trial. We look forward to the arrival of other catheter 
techniques, lasers and stems. It is highly likely that with the 
additional armamentarium consisting of atherectomy, laser, and 
stents that most coronary obstructions will be amenable to catheter 
intervention; emergency coronary bypass for failed PTCA will be 
a thing of the past. However, we are not looking forward to the 
proliferation of molecular biologists, who may make interventional 
cardiologists and cardiovascular surgeons a thing of the past. 
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